Cover Image

Role of diagnostic stewardship in reducing healthcare facility-onset Clostridioides difficile infections

Show other versions (1)

Background: Clostridioides difficile infection (CDI) is the most common healthcare-associated infection (HAI) in the United States. Healthcare facility-onset (HO) CDI reporting is a laboratory-identified (LabID) event and does not rely on symptoms. Inappropriate testing can lead to overdiagnosis in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anita Shallal (Author), Medha Cherabuddi (Author), Lance Podsiad (Author), Christopher Gortat (Author), Clare Shanahan (Author), Jessica Kirkpatrick (Author), Eman Chami (Author), Stephanie Schuldt (Author), Tarlisha Holsey (Author), Martin Levesque (Author), George Alangaden (Author), Geehan Suleyman (Author)
Format:	Book
Published:	Cambridge University Press, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of diagnostic stewardship in reducing healthcare-facility-onset Clostridioides difficile infections
by: Anita B. Shallal, et al.
Published: (2023)

Hospital-Onset Clostridioides difficile infection in chronic kidney disease patients
by: Anita Shallal, et al.
Published: (2024)

Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
by: Andrew T. Dysangco, et al.
Published: (2022)

Risk Factors and Outcomes of Candida auris in Southeast Michigan
by: Ambreen Malik, et al.
Published: (2024)

Prospective Review of Clostridioides difficile Testing Indications to Inform Local Laboratory Stewardship Initiatives
by: Noah Reich, et al.
Published: (2019)

Clostridioides difficile Infection
Published: (2022)

Diagnostic stewardship for Clostridioides difficile testing in an acute care hospital: A quality improvement intervention
by: Madeline L. Berg, et al.
Published: (2023)

Optimizing the interpretation of Clostridioides difficile two-step diagnostic algorithm results through antimicrobial stewardship
by: Christopher F. Lowe, et al.
Published: (2022)

Diagnostic Methods of <i>Clostridioides difficile</i> Infection and <i>Clostridioides difficile</i> Ribotypes in Studied Sample
by: Elena Novakova, et al.
Published: (2021)

Clostridioides difficile: A diagnostic intervention
by: Majd Alsoubani, et al.
Published: (2022)

Reductions in inpatient fluoroquinolone use and postdischarge Clostridioides difficile infection (CDI) from a systemwide antimicrobial stewardship intervention
by: K. Ashley Jones, et al.
Published: (2021)

Evaluating outpatient diagnostic stewardship of comprehensive polymerase chain reaction Clostridioides difficile testing in a regional health system
by: Ilya Golovaty, et al.
Published: (2023)

Implementation of multifaceted diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital
by: Yasuhiro Sasaki, et al.
Published: (2024)

Expansion of a versatile pathogen: Clostridioides difficile
by: Tereena Lucas, et al.
Published: (2024)

Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
by: Oliver MB, et al.
Published: (2022)

Impact of a Diagnosis-Centered Antibiotic Stewardship on Incident <i>Clostridioides difficile</i> Infections in Older Inpatients: An Observational Study
by: Alain Putot, et al.
Published: (2020)

Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients
by: Diaa Alrahmany, et al.
Published: (2021)

Outbreak of Clostridioides difficile infection in Silesian district hospital
by: Klaudia T. Szarek, et al.
Published: (2023)

Introduction to the Special Issue on <i>Clostridioides difficile</i>
by: Guido Granata, et al.
Published: (2021)

Opportunities for Nanomedicine in <i>Clostridioides difficile</i> Infection
by: Pei-Wen Wang, et al.
Published: (2021)

Clostridioides Difficile Enteritis: Case Report and Literature Review
by: Artsiom Klimko, et al.
Published: (2022)

Current Diagnostic and Treatment Approach of Clostridioides difficile Infection
by: Bella Yunita, et al.
Published: (2023)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021)

Impact of Clostridioides difficile Reporting on Antimicrobial Therapy Days Directed at Treatment of C. difficile Infections
by: Ardath Plauche, et al.
Published: (2024)

The accuracy of fully automated algorithms for surveillance of healthcare-onset Clostridioides difficile infections in hospitalized patients
by: Suzanne Desirée van der Werff, et al.
Published: (2022)

Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection
by: Jesse Fajnzylber, et al.
Published: (2024)

Clostridioides Difficile: A Concise Review of Best Practices and Updates
by: Abdelrahman Yakout, et al.
Published: (2024)

Clostridioides difficile infections in Saudi Arabia: Where are we standing?
by: Najla A. Obaid, et al.
Published: (2020)

Clostridioides difficile infection in intensive care units in nursing practice
by: Izabela Fajfer-Gryz, et al.
Published: (2020)

Clostridioides difficile infection: a comprehensive review for primary providers
by: Cortés Pedro, et al.
Published: (2021)

Clostridioides difficile infection leading to fulminant colitis with toxic megacolon
by: Fareed Rajack, et al.
Published: (2023)

Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya
by: Winnie C. Mutai, et al.
Published: (2022)

Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya.
by: Winnie C Mutai, et al.
Published: (2022)

Clostridioides difficile infection in trials of short versus long duration of antimicrobials
by: Dimitri M. Drekonja, et al.
Published: (2024)

Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
by: Zeitler Kristen, et al.
Published: (2023)

Improving Culture yield rates for clostridioides difficile by using CHROMagarTM
by: T. Yi-Chun, et al.
Published: (2020)

The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study
by: Uffe Christian Braae, et al.
Published: (2020)

Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore Outgrowth
by: Suvash Chandra Ojha, et al.
Published: (2021)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
by: Sebastian Heber, et al.
Published: (2022)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
by: Kullar R, et al.
Published: (2020)